am1030
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02379910)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Serotonin 2b (5-HT2b) receptorINHIBITOR
HTR2B inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- am1030
- am1030
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02379910 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2014 | AnaMar AB, Covance |
Showing 1 of 1 trials
Page 1 / 1